Personal information

Activities

Works (50 of 107)

Items per page:
Page 1 of 3

Rucaparib in refractory pleural mesothelioma harboring somatic pathogenic BRCA1 and BRCA2 mutation. A report of two cases

Lung Cancer Management
2025-12-31 | Journal article
Contributors: Luigi Cerbone; Benedetta del Rio; Sara Delfanti; Francesco Boccuzzi; Paola Barbieri; Antonina Maria De Angelis; Stefano Meda; Laura Savi; Luisella Righi; Marika Sculco et al.
Source: check_circle
Crossref

Clinical and Molecular Traits of a Novel SPECC1L-ALK Fusion in a Patient with Advanced Non-Small Cell Lung Cancer

Journal of Personalized Medicine
2024-06 | Journal article | Author
Contributors: Antonella Centonza; Tommaso Mazza; Domenico Trombetta; Angelo Sparaneo; Francesco Petrizzelli; Stefano Castellana; Flavia Centra; Federico Pio Fabrizio; Concetta Martina Di Micco; Federica Benso et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report

Journal of Personalized Medicine
2024-04-08 | Journal article
Contributors: Giulio Rossi; Luisella Righi; Francesca Barbisan; Marcello Tiseo; Paolo Spagnolo; Federica Grosso; Pasquale Pisapia; Umberto Malapelle; Marika Sculco; Irma Dianzani et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Data from Niraparib plus Dostarlimab in Pleural Mesothelioma or Non–Small Cell Lung Cancer Harboring <i>HRR</i> Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial

2024-03-01 | Preprint
Contributors: Francesco Passiglia; Luisella Righi; Paolo Bironzo; Angela Listì; Giovanni Farinea; Enrica Capelletto; Silvia Novello; Alessandra Merlini; Giorgio V. Scagliotti
Source: check_circle
Crossref

Data from Niraparib plus Dostarlimab in Pleural Mesothelioma or Non–Small Cell Lung Cancer Harboring <i>HRR</i> Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial

2024-03-01 | Preprint
Contributors: Francesco Passiglia; Luisella Righi; Paolo Bironzo; Angela Listì; Giovanni Farinea; Enrica Capelletto; Silvia Novello; Alessandra Merlini; Giorgio V. Scagliotti
Source: check_circle
Crossref

Niraparib plus Dostarlimab in Pleural Mesothelioma or Non–Small Cell Lung Cancer Harboring HRR Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial

Clinical Cancer Research
2024-03-01 | Journal article
Contributors: Francesco Passiglia; Luisella Righi; Paolo Bironzo; Angela Listì; Giovanni Farinea; Enrica Capelletto; Silvia Novello; Alessandra Merlini; Giorgio V. Scagliotti
Source: check_circle
Crossref

Supplementary Figure 1 from Niraparib plus Dostarlimab in Pleural Mesothelioma or Non–Small Cell Lung Cancer Harboring <i>HRR</i> Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial

2024-03-01 | Preprint
Contributors: Francesco Passiglia; Luisella Righi; Paolo Bironzo; Angela Listì; Giovanni Farinea; Enrica Capelletto; Silvia Novello; Alessandra Merlini; Giorgio V. Scagliotti
Source: check_circle
Crossref

Supplementary Figure 1 from Niraparib plus Dostarlimab in Pleural Mesothelioma or Non–Small Cell Lung Cancer Harboring <i>HRR</i> Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial

2024-03-01 | Preprint
Contributors: Francesco Passiglia; Luisella Righi; Paolo Bironzo; Angela Listì; Giovanni Farinea; Enrica Capelletto; Silvia Novello; Alessandra Merlini; Giorgio V. Scagliotti
Source: check_circle
Crossref

Supplementary Figure 2 from Niraparib plus Dostarlimab in Pleural Mesothelioma or Non–Small Cell Lung Cancer Harboring <i>HRR</i> Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial

2024-03-01 | Preprint
Contributors: Francesco Passiglia; Luisella Righi; Paolo Bironzo; Angela Listì; Giovanni Farinea; Enrica Capelletto; Silvia Novello; Alessandra Merlini; Giorgio V. Scagliotti
Source: check_circle
Crossref

Supplementary Figure 2 from Niraparib plus Dostarlimab in Pleural Mesothelioma or Non–Small Cell Lung Cancer Harboring <i>HRR</i> Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial

2024-03-01 | Preprint
Contributors: Francesco Passiglia; Luisella Righi; Paolo Bironzo; Angela Listì; Giovanni Farinea; Enrica Capelletto; Silvia Novello; Alessandra Merlini; Giorgio V. Scagliotti
Source: check_circle
Crossref

Supplementary Figure 3 from Niraparib plus Dostarlimab in Pleural Mesothelioma or Non–Small Cell Lung Cancer Harboring <i>HRR</i> Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial

2024-03-01 | Preprint
Contributors: Francesco Passiglia; Luisella Righi; Paolo Bironzo; Angela Listì; Giovanni Farinea; Enrica Capelletto; Silvia Novello; Alessandra Merlini; Giorgio V. Scagliotti
Source: check_circle
Crossref

Supplementary Figure 3 from Niraparib plus Dostarlimab in Pleural Mesothelioma or Non–Small Cell Lung Cancer Harboring <i>HRR</i> Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial

2024-03-01 | Preprint
Contributors: Francesco Passiglia; Luisella Righi; Paolo Bironzo; Angela Listì; Giovanni Farinea; Enrica Capelletto; Silvia Novello; Alessandra Merlini; Giorgio V. Scagliotti
Source: check_circle
Crossref

Supplementary Table 1 from Niraparib plus Dostarlimab in Pleural Mesothelioma or Non–Small Cell Lung Cancer Harboring <i>HRR</i> Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial

2024-03-01 | Preprint
Contributors: Francesco Passiglia; Luisella Righi; Paolo Bironzo; Angela Listì; Giovanni Farinea; Enrica Capelletto; Silvia Novello; Alessandra Merlini; Giorgio V. Scagliotti
Source: check_circle
Crossref

Supplementary Table 1 from Niraparib plus Dostarlimab in Pleural Mesothelioma or Non–Small Cell Lung Cancer Harboring <i>HRR</i> Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial

2024-03-01 | Preprint
Contributors: Francesco Passiglia; Luisella Righi; Paolo Bironzo; Angela Listì; Giovanni Farinea; Enrica Capelletto; Silvia Novello; Alessandra Merlini; Giorgio V. Scagliotti
Source: check_circle
Crossref

Supplementary Table 2 from Niraparib plus Dostarlimab in Pleural Mesothelioma or Non–Small Cell Lung Cancer Harboring <i>HRR</i> Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial

2024-03-01 | Preprint
Contributors: Francesco Passiglia; Luisella Righi; Paolo Bironzo; Angela Listì; Giovanni Farinea; Enrica Capelletto; Silvia Novello; Alessandra Merlini; Giorgio V. Scagliotti
Source: check_circle
Crossref

Supplementary Table 2 from Niraparib plus Dostarlimab in Pleural Mesothelioma or Non–Small Cell Lung Cancer Harboring <i>HRR</i> Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial

2024-03-01 | Preprint
Contributors: Francesco Passiglia; Luisella Righi; Paolo Bironzo; Angela Listì; Giovanni Farinea; Enrica Capelletto; Silvia Novello; Alessandra Merlini; Giorgio V. Scagliotti
Source: check_circle
Crossref

Deciphering Lung Adenocarcinoma Heterogeneity: An Overview of Pathological and Clinical Features of Rare Subtypes

Life
2023-05-31 | Journal article
Contributors: Andrea Mogavero; Paolo Bironzo; Luisella Righi; Alessandra Merlini; Federica Benso; Silvia Novello; Francesco Passiglia
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Genetic Ablation of the MET Oncogene Defines a Crucial Role of the HGF/MET Axis in Cell-Autonomous Functions Driving Tumor Dissemination

Cancers
2023-05-13 | Journal article
Contributors: Chiara Modica; Marco Cortese; Francesca Bersani; Andrea Maria Lombardi; Francesca Napoli; Luisella Righi; Riccardo Taulli; Cristina Basilico; Elisa Vigna
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer

Cells
2022-10 | Journal article | Author
Contributors: Annapaola Mariniello; Fabrizio Tabbò; Davide Indellicati; Martina Tesauro; Nicole Alessia Rezmives; Maria Lucia Reale; Angela Listì; Enrica Capelletto; SIMONA CARNIO; Valentina Bertaglia et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Clinical-Molecular Prospective Cohort Study in Non-Small Cell Lung Cancer (PROMOLE study): A Comprehensive Approach to Identify New Predictive Markers of Pharmacological Response

Clinical Lung Cancer
2022-09 | Journal article
Contributors: Paolo Bironzo; Luca Primo; Silvia Novello; Luisella Righi; Silvana Candeloro; Lorenzo Manganaro; Federico Bussolino; Fabrizio Pirri; Giorgio V. Scagliotti
Source: check_circle
Crossref

Diagnostics of <i>BAP1</i>-Tumor Predisposition Syndrome by a Multitesting Approach: A Ten-Year-Long Experience

Diagnostics
2022-07 | Journal article | Author
Contributors: Marika Sculco; Marta La Vecchia; Anna Aspesi; Michela Giulia Clavenna; Michela Salvo; Giulia Borgonovi; Alessandra Pittaro; Gianluca Witel; Francesca Napoli; Angela Listì et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

NSCLC Biomarkers to Predict Response to Immunotherapy with Checkpoint Inhibitors (ICI): From the Cells to In Vivo Images

Cancers
2021-09 | Journal article | Author
Contributors: Virginia Liberini; Annapaola Mariniello; Luisella Righi; Martina Capozza; Marco Donatello Delcuratolo; Enzo TERRENO; Mohsen Farsad; Marco Volante; Silvia Novello; Désirée Deandreis
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Pathological Characterization of Tumor Immune Microenvironment (TIME) in Malignant Pleural Mesothelioma

Cancers
2021-05 | Journal article | Author
Contributors: Francesca Napoli; Angela Listi; Vanessa Zambelli; Gianluca Witel; Paolo Bironzo; Mauro Papotti; Marco Volante; Giorgio Scagliotti; Luisella Righi
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective

Critical Reviews in Oncology/Hematology
2021-04 | Journal article
Contributors: Umberto Malapelle; Sara Pilotto; Francesco Passiglia; Francesco Pepe; Pasquale Pisapia; Luisella Righi; Angela Listì; Paolo Bironzo; Lorenzo Belluomini; Fabrizio Tabbò et al.
Source: check_circle
Crossref

Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment

OncoImmunology
2018 | Journal article
EID:

2-s2.0-85035093142

Contributors: Riganti, C.; Lingua, M.F.; Salaroglio, I.C.; Falcomatà, C.; Righi, L.; Morena, D.; Picca, F.; Oddo, D.; Kopecka, J.; Pradotto, M. et al.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier

Human renal angiomyolipoma cells of male and female origin can migrate and are influenced by microenvironmental factors

PLoS ONE
2018 | Journal article
EID:

2-s2.0-85048751114

Contributors: Bertolini, F.; Casarotti, G.; Righi, L.; Bollito, E.; Albera, C.; Racca, S.A.; Colangelo, D.; Mognetti, B.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier

Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma

Lung Cancer
2018 | Journal article
EID:

2-s2.0-85044532728

Contributors: Kopecka, J.; Salaroglio, I.C.; Righi, L.; Libener, R.; Orecchia, S.; Grosso, F.; Milosevic, V.; Ananthanarayanan, P.; Ricci, L.; Capelletto, E. et al.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier

Molecular and Histopathological Characterization of the Tumor Immune Microenvironment in Advanced Stage of Malignant Pleural Mesothelioma

Journal of Thoracic Oncology
2018 | Journal article
EID:

2-s2.0-85039943093

Contributors: Patil, N.S.; Righi, L.; Koeppen, H.; Zou, W.; Izzo, S.; Grosso, F.; Libener, R.; Loiacono, M.; Monica, V.; Buttigliero, C. et al.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier

Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based Proposal

Journal of Thoracic Oncology
2018 | Journal article
EID:

2-s2.0-85053039670

Contributors: Pelosi, G.; Papotti, M.; Righi, L.; Rossi, G.; Ferrero, S.; Bosari, S.; Calabrese, F.; Kern, I.; Maisonneuve, P.; Sonzogni, A. et al.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier

Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes

Genes Chromosomes and Cancer
2018 | Journal article
EID:

2-s2.0-85055073569

Contributors: Betti, M.; Aspesi, A.; Ferrante, D.; Sculco, M.; Righi, L.; Mirabelli, D.; Napoli, F.; Rondón-Lagos, M.; Casalone, E.; Vignolo Lutati, F. et al.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier

Soluble CD157 in pleural effusions: A complementary tool for the diagnosis of malignant mesothelioma

Oncotarget
2018 | Journal article
EID:

2-s2.0-85046099959

Contributors: Augeri, S.; Capano, S.; Morone, S.; Fissolo, G.; Giacomino, A.; Peola, S.; Drace, Z.; Rapa, I.; Novello, S.; Volante, M. et al.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier

Validation of the diagnosis of mesothelioma and BAP1 protein expression in a cohort of asbestos textile workers from Northern Italy

Annals of Oncology
2018 | Journal article
EID:

2-s2.0-85042558570

Contributors: Boffetta, P.; Righi, L.; Ciocan, C.; Pelucchi, C.; La Vecchia, C.; Romano, C.; Papotti, M.; Pira, E.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier

What's new in mesothelioma

Pathologica
2018 | Journal article
EID:

2-s2.0-85054571872

Contributors: Ascoli, V.; Murer, B.; Nottegar, A.; Luchini, C.; Carella, R.; Calabrese, F.; Lunardi, F.; Cozzi, I.; Righi, L.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier

Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpression

European Respiratory Journal
2017 | Journal article
EID:

2-s2.0-85029470172

Contributors: Di Stefano, A.; Ricciardolo, F.L.M.; Caramori, G.; Adcock, I.M.; Chung, K.F.; Barnes, P.J.; Brun, P.; Leonardi, A.; Andò, F.; Vallese, D. et al.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier

Classification of pulmonary neuroendocrine tumors: New insights

Translational Lung Cancer Research
2017 | Journal article
EID:

2-s2.0-85030976083

Contributors: Pelosi, G.; Sonzogni, A.; Harari, S.; Albini, A.; Bresaola, E.; Marchiò, C.; Massa, F.; Righi, L.; Gatti, G.; Papanikolaou, N. et al.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier

Diffusion-weighted quantitative MRI of pleural abnormalities: Intra- and interobserver variability in the apparent diffusion coefficient measurements

Journal of Magnetic Resonance Imaging
2017 | Journal article
EID:

2-s2.0-85021071730

Contributors: Priola, A.M.; Priola, S.M.; Gned, D.; Giraudo, M.T.; Brundu, M.; Righi, L.; Veltri, A.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier

Does immunohistochemistry represent a robust alternative technique in determining drugable predictive gene alterations in non-small cell lung cancer?

Current Drug Targets
2017 | Journal article
EID:

2-s2.0-85026797225

Contributors: Rossi, G.; Ragazzi, M.; Tamagnini, I.; Mengoli, M.C.; Vincenzi, G.; Barbieri, F.; Piccioli, S.; Bisagni, A.; Vavalà, T.; Righi, L. et al.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)-from morphology to molecular testing

Journal of Thoracic Disease
2017 | Journal article
EID:

2-s2.0-85019614177

Contributors: Righi, L.; Franzi, F.; Montarolo, F.; Gatti, G.; Bongiovanni, M.; Sessa, F.; La Rosa, S.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier

Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma

Cancer Letters
2017 | Journal article
EID:

2-s2.0-85026556793

Contributors: Betti, M.; Casalone, E.; Ferrante, D.; Aspesi, A.; Morleo, G.; Biasi, A.; Sculco, M.; Mancuso, G.; Guarrera, S.; Righi, L. et al.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier

Helical-Tip Needle for Transthoracic Percutaneous Image-Guided Biopsy of Lung Tumors: Results of a Pilot Prospective Comparative Study with a Standard Tru-Cut Needle

CardioVascular and Interventional Radiology
2017 | Journal article
EID:

2-s2.0-85010723506

Contributors: Veltri, A.; Busso, M.; Sardo, D.; Angelino, V.; Priola, A.M.; Novello, S.; Barba, M.; Gatti, G.; Righi, L.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier

Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied

Virchows Archiv
2017 | Journal article
EID:

2-s2.0-85008147241

Contributors: Fabbri, A.; Cossa, M.; Sonzogni, A.; Papotti, M.; Righi, L.; Gatti, G.; Maisonneuve, P.; Valeri, B.; Pastorino, U.; Pelosi, G.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier

Lung neuroendocrine tumors: Pathological characteristics

Journal of Thoracic Disease
2017 | Journal article
EID:

2-s2.0-85033489806

Contributors: Righi, L.; Gatti, G.; Volante, M.; Papotti, M.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier

Multicenter Comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) Assays to Test PD-L1 Expression for NSCLC Patients to Be Treated with Immune Checkpoint Inhibitors

Journal of Thoracic Oncology
2017 | Journal article
EID:

2-s2.0-85029164781

Contributors: Marchetti, A.; Barberis, M.; Franco, R.; De Luca, G.; Pace, M.V.; Staibano, S.; Volante, M.; Buttitta, F.; Guerini-Rocco, E.; Righi, L. et al.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier

Precision medicine in age-specific non-small-cell-lung-cancer patients: Integrating biomolecular results into clinical practice—A new approach to improve personalized translational research

Lung Cancer
2017 | Journal article
EID:

2-s2.0-85006379675

Contributors: Vavalà, T.; Monica, V.; Lo Iacono, M.; Mele, T.; Busso, S.; Righi, L.; Papotti, M.; Scagliotti, G.V.; Novello, S.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier

BRCA1- A ssociated protein 1 (BAP1) immunohistochemical expression as a diagnostic tool in malignant pleural mesothelioma classification: A large retrospective study

Journal of Thoracic Oncology
2016 | Journal article
EID:

2-s2.0-84995906137

Contributors: Righi, L.; Duregon, E.; Vatrano, S.; Izzo, S.; Giorcelli, J.; Rondón-Lagos, M.; Ascoli, V.; Ruffini, E.; Ventura, L.; Volante, M. et al.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier

CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma

Cancer Letters
2016 | Journal article
EID:

2-s2.0-84976330532

Contributors: Betti, M.; Aspesi, A.; Biasi, A.; Casalone, E.; Ferrante, D.; Ogliara, P.; Gironi, L.C.; Giorgione, R.; Farinelli, P.; Grosso, F. et al.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier

Mesothelioma families without inheritance of a BAP1 predisposing mutation

Cancer Genetics
2016 | Journal article
EID:

2-s2.0-84992170512

Contributors: Ascoli, V.; Cozzi, I.; Vatrano, S.; Izzo, S.; Giorcelli, J.; Romeo, E.; Carnovale-Scalzo, C.; Grillo, L.R.; Facciolo, F.; Visca, P. et al.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier

Molecular and Histological Changes in Post-Treatment Biopsies of Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study

Targeted Oncology
2016 | Journal article
EID:

2-s2.0-84940054797

Contributors: Vatrano, S.; Righi, L.; Vavalá, T.; Rapa, I.; Busso, M.; Izzo, S.; Cappia, S.; Veltri, A.; Papotti, M.; Scagliotti, G.V. et al.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier

Retrospective multicenter study investigating the role of targeted next-generation sequencing of selected cancer genes in mucinous adenocarcinoma of the lung

Journal of Thoracic Oncology
2016 | Journal article
EID:

2-s2.0-84962878145

Contributors: Righi, L.; Vatrano, S.; Di Nicolantonio, F.; Massa, F.; Rossi, G.; Cavazza, A.; Volante, M.; Votta, A.; Izzo, S.; Iacono, M.L. et al.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier

An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation

Cancer Genetics
2015 | Journal article
EID:

2-s2.0-84942500533

Contributors: Cheung, M.; Kadariya, Y.; Pei, J.; Talarchek, J.; Facciolo, F.; Visca, P.; Righi, L.; Cozzi, I.; Testa, J.R.; Ascoli, V.
Source: Self-asserted source
Luisella Righi via Scopus - Elsevier
Items per page:
Page 1 of 3

Peer review (6 reviews for 4 publications/grants)

Review activity for Cellular oncology. (1)
Review activity for Heliyon. (1)
Review activity for Journal of cancer metastasis and treatment. (3)
Review activity for The Lancet. (1)